Skip to main content
ETST
OTC Life Sciences

Earth Science Tech Upgrades Audit Capabilities, Engages New PCAOB Auditor

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$0.12
Mkt Cap
$34.967M
52W Low
$0.001
52W High
$0.237
Market data snapshot near publication time

summarizeSummary

Earth Science Tech, Inc. announced the resignation of its previous auditor and the engagement of Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor, citing a strategic upgrade to support its expanding operations.


check_boxKey Events

  • Auditor Resignation

    Stephano Slack LLC resigned as the independent registered public accounting firm for Earth Science Tech, Inc. on February 17, 2026.

  • No Disagreements or Reportable Events

    The company confirmed there were no disagreements on accounting principles, financial disclosure, or auditing scope, nor were there any reportable events with the resigning auditor.

  • New Auditor Engaged

    Semple, Marchal & Cooper, LLP was engaged as the new independent Public Company Accounting Oversight Board (PCAOB) auditor, effective February 17, 2026.

  • Strategic Upgrade for Growth

    The company stated this transition represents a strategic upgrade in its financial governance infrastructure to optimize auditing efficiencies and match its current operational scale and complexity amidst rapid expansion.


auto_awesomeAnalysis

This 8-K details a significant corporate governance update, providing specific information following a broader strategic plan announced on the same day. Earth Science Tech, Inc. has changed its independent registered public accounting firm, with Stephano Slack LLC resigning and Semple, Marchal & Cooper, LLP being appointed. Crucially, the filing explicitly states there were no disagreements or reportable events with the resigning auditor, mitigating potential negative concerns often associated with auditor changes. The company frames this as a strategic move to enhance audit capabilities and support its increasingly complex financial structure as it expands. Investors should view this as a proactive step to strengthen financial oversight and align with the company's growth trajectory.

At the time of this filing, ETST was trading at $0.12 on OTC in the Life Sciences sector, with a market capitalization of approximately $35M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ETST - Latest Insights

ETST
Mar 24, 2026, 9:07 AM EDT
Filing Type: 8-K
Importance Score:
7
ETST
Feb 20, 2026, 1:49 PM EST
Filing Type: 8-K
Importance Score:
7
ETST
Feb 17, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
ETST
Feb 13, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
ETST
Jan 06, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
ETST
Jan 05, 2026, 9:06 AM EST
Filing Type: 8-K
Importance Score:
7